Skip to content

Quality of Life and Addiction Among Hospital Night Workers

Quality of Life and Addiction Among Hospital Night Workers - Descriptive Study of APHP Workers in Paris

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04291534
Acronym
ALADDIN
Enrollment
1800
Registered
2020-03-02
Start date
2020-06-15
Completion date
2023-06-01
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction, Health Personnel, Health Services Research, Quality of Life, Substance-Related Disorders

Brief summary

The current context of the Covid-19 health crisis leads to an over-solicitation of health systems, with hospital staff in the front line. These personnel are undergoing high levels of stress, an alteration of their life rhythm, but also of their health status and quality of life at work. In addition, night work, through the disruption of circadian rhythms, has consequences on physical and mental health. The more frequent worsening of the condition of certain patients at night increases the burden and responsibilities of night staff. Increasing the use of psychoactive substances (SPAs) can become a solution for managing stress, work rhythms, sleep disorders and their consequences. This self-medication behaviour is not without risks, neither for staff nor for patients. The ALADDIN study is a project made up of 2 waves of questionnaires - one during and the other after the Covid hospital crisis - filled in by the hospital night staff of AP-HP. This project will assess the impact of the Covid-19 epidemic on the quality of work life, mental health disorders, post-traumatic stress and substance use of hospital night staff. The main objectives of this study is to evaluate the prevalence of psychoactive substance consumption among the night shift healthcare workers of the AP-HP and to describe the participants' quality of working life. Methods The study is prospective study using an online self-completed questionnaire. The questionnaire was elaborated on the basis of the validated scales ASSIST (Alcohol, Smoking, and Substance Involvement Screening Test), AUDIT-C (Alcohol Use Disorder Test, shortened version) and HAD (for anxiety and depression) and on qualitative interviews conducted among care staff working the night shift. The questionnaire will be completed at t0 (baseline) and 18 months after. This study will provide data on the consumption psychoactive substances by night hospital workers adn their quality of working life. It will also allow us to compare their consumption with the general population, and to describe the risk factors influencing the consumption.

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
University Paris 7 - Denis Diderot
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 67 Years

Inclusion criteria

\- hospital workers at APHP, working at night or night and day alternance (working at least 3 hours between 9 p.m and 6 a.m, 2 times a week)

Exclusion criteria

* Hospital workers working during the day * Workers working less than 3 hours a night two time a week * Doctors

Design outcomes

Primary

MeasureTime frameDescription
Substance use prevalenceat T0 month : baselinePrevalence in APHP health workers of psychoactive substance consumption during the Covid 19 outbreak
Quality of working life scaleat T0 month : baselineEvaluation of the quality of working life during the Covid 19 outbreak using a validated scale

Secondary

MeasureTime frameDescription
Intervention preferenceat T0 monthIdentify the preferences for intervention to improve the quality of life or change the addictive risk of night hospital staff at the APHP. Preferences for intervention methods and ranking of the least preferred.
Psychoactive substance consumption and associated factorsat T0 monthDescribe the risk factors associated with the consumption of psychoactive substances (PAS). Logistic or fish linear regression depending on the type of variable taken into account.
Impact of substance consumption on quality of life at workat T0 monthEvaluate the impact of substance use on quality of life at work Principal component analysis and classification to see if there are consumer groups for the night and / or day population. Method for taking into account missing, unused or invalid data
Risk factors associated with tobacco useat T0 monthDescribe the risk factors associated with tobacco use among night hospital workers,
Impact of sleep and workplace upheaval on anxiety and depressives symptomsat T monthDescribe the links between anxiety/depressive syndromes and workplace disruption, sleep, and the Covid epidemic.
Modification of quality of working life score and psychoactive substances consumption prevalencesT18 monthsComparison between the baseline score and prevalences and the score and prevalences 18 months after
Comparison of modification of quality of life score and declared quality of life modification after 18 monthT18 monthsAnalysis of the relation between declared change and evolution of the quality of life score
Impact of anxiety and depressive symptoms on sleep and QWL.at T0 monthDescribe the links between QWL and sleep, anxiety, depressive syndromes, and workplace upheaval.
Impact of sleep quality on quality of working life and perceived healthat T0 monthEvaluate the impact of sleep quality on the quality of working life and perceived health of night staff

Countries

France

Contacts

Primary ContactLorraine COUSIN, PhDc
cousinlorraine@gmail.comlorraine.cousin-ext@aphp.fr0683586227
Backup ContactOlivia Rousset Torrente, MD
olivia.rousset-torrente-ext@aphp.fr0140274689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026